Dr. David Najarian graduated from the University of Michigan, Ann Arbor with a Bachelor of Science in Microbiology, earning Highest Honors and Highest Distinction.
Dr. Najarian spent his first year after graduation inventing an electronics device, "Remote Device for Silent Awakening." This device received U.S. patent number 6,151,278. He then went to work as a biochemist at Schering Plough in Kenilworth, NJ. During his year there, his research group discovered the mechanism of action of a novel antibiotic, Evernimicin, and won the company's highest research award, the Presidential Award for Research.
Dr. Najarian then went to medical school at the University of Virginia in Charlottesville. After finishing medical school he completed a one year internship in internal medicine at Albert Einstein College of Medicine, Montefiore, NY, and then enrolled at University of Medicine and Dentistry of New Jersey in New Brunswick, NJ for his dermatology residency. He then completed a one year skin cancer surgery fellowship at the Roswell Park Cancer Institute, Buffalo, NY, which was sponsored by the American College of Mohs Surgery.
Dr. Najarian started the practice in 2008 in his hometown of Randolph, initially borrowing office space from his beloved father, James S. Najarian, M.D. and Steven M. Gudis, M.D., at Randolph Medical and Renal Associates. In 2011 the dermatology practice moved down the block to 390 Route 10 West, Suite 102. Then, in 2016 the practice moved upstairs in the same building to Suite 201.
Dr. Najarian served on the editorial board of the Journal of the American Academy of Dermatology (JAAD) from 2008 to 2018, at which point the JAAD was the world’s most widely read dermatology journal in the world, according to Kantar media. Moreover, in 2016 Thomson Reuters named the JAAD the top peer-reviewed dermatology journal with the highest impact factor. Finally, in 2009 the Special Libraries Association named JAAD one of the most 100 influential journals of the past 100 years.
Dr. Najarian has been certified by the American Board of Dermatology continuously since 2008. He is also an elected fellow of the American College of Mohs surgery. Finally, Dr. Najarian is a member of the American Contact Dermatitis Society.